Detection of fetal fibronectin in twin pregnancies in relation to gestational age
Keywords:
Twins, Fetal fibronectin, Preterm deliveryAbstract
CONTEXT: The presence of fetal fibronectin in the cervix or vagina has been investigated as a possible marker for the risk of preterm birth. Fetal fibronectin in cervical fluid can provide direct evidence of pathologic changes at the interface of fetal and maternal tissues. OBJECTIVE: To evaluate the presence of fetal fibronectin as a predictor of premature delivery in twin pregnancies in relation to gestational age. DESIGN: Acuracy study. SETTING: University referral unit. PARTICIPANTS: 52 pregnant women with twin pregnancies and gestational age of between 24 and 34 weeks. MAIN MEASUREMENTS: Sensivity, specifity, predictive values and relative risk ratios of the correlation between fetal fibronectin and preterm birth before 34 and 37 weeks using an immediate-reading membrane test on cervicovaginal secretions obtained from participants. RESULT: The sensitivity varied between 66.7% and 85.7%, whereas the specificity was from 58.3% to 81.8% according to gestational age at the time of sampling. The relative risk of spontaneous preterm birth after a positive fetal fibronectin test, as compared with a negative fetal fibronectin test, rose from 2.8 at 24-26 weeks to 4.1 at 27-30 weeks. Analyses of the risk of delivery before 34 weeks were not statistically significant. CONCLUSION: Fetal fibronectin in the cervicovaginal secretions of patients with twin pregnancies is a useful tool for the early identification of twin pregnancies likely to deliver before 37 weeks. However, the clinical value of the fibronectin test is limited because of low indices for prediction of delivery before 34 weeks. The best period for performing the fetal fibronectin test in twin pregnancies to predict preterm delivery is between 27 and 30 weeks.
Downloads
References
Creasy RK, Merkatz IR. Prevention of preterm birth: Clinical opinion. Obstet Gynecol 1990;76:2s-4s.
Garite TJ, Lockwood CJ. A new test for diagnosis and prediction of preterm delivery. Contemporary Ob/Gyn 1996;41:77-93.
Ho SK, Wu LYK. Perinatal factors and neonatal morbidity in twin pregnancy. Am J Obstet Gynecol 1975;122:979-87.
Spellacy WN, Hondier A, Fene CD. A case-control study of 1253 twin pregnancies from a 1982-1987 perinatal data base. Obstet Gynecol 1990;75:168-71.
Dor J, Shaley J, Masiach J, Blankstein J, Serr DM. Elective cervical suture of twin pregnancies diagnosed ultrasonically in the first trimester following ovulation. Gynecol Obstet Invest 1982;13:55-60.
Crowther CA, Neilson JP, Ashurst HM, Verkuryl DA, Bannerman C. The effects of hospitalization for rest on fetal growth, neonatal morbidity and length of gestation in twin pregnancy. Br J Obstet Gynecol 1990;97:872-7.
Preventive Task Force. Home uterine activity monitoring for preterm labor: review article. JAMA 1993;270:371-6.
Ashworth MF, Spooner SF, Verkuryl DA, Waterman R, Ashurst HM. Failure to prevent preterm labour and delivery in twin pregnancy using prophylactic oral salbutamol. Br J Obstet Gynecol 1990;97:878-82.
Maclennan AH, Green RC, OShea R, Brookes C, Morris D. Routine hospital admission in twin pregnancies between 26 and 30 weeks gestation. Lancet 1990;335:267-9.
Grothe W, Ruttgers H. Twin pregnancies: an 11-year review. Acta Genet Med Gemellol 1985;34:49-58.
Bittar RE, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectin in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175(1):178-81.
Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Meis PJ, Das A, McNellis D, Miodovnik M, Menard MK, Caritis S, Thurnau GR, Bottoms SF. National Institute of Child Health, Human Development Maternal-Fetal Medicine Units Network. The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm delivery. Am J Obstet Gynecol 1997;177:8-12.
Nageotte MP, Casal D, Senyei AE. Fetal fibronectin in patients at increased risk for premature birth. Am J Obstet Gynecol 1994;170(1pt1):20-5.
Tolino A, Ronsini S, Zullo F, Pellicano M, Regine V, Nappi C. Fetal fibronectin as a screening test for premature delivery in multiple pregnancies. Int J Gynecol Obstet 1996;52(1):3-7.
